However, PCDH10 promoter hypermethylation is a frequent hallmark observed during the progression of cervical and endometrial cancers, as previously reported (Narayan et al. 2009; Wang et al. 2009; Zhao et al. 2014; Bhat et al. 2017). This evidence concerns the gene PCDH10 and endometrial cancer.